Published in Cancer Lett on March 25, 2010
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. PLoS Pathog (2015) 2.19
Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology (2012) 1.33
HDAC inhibitors and immunotherapy; a double edged sword? Oncotarget (2014) 0.97
Immune effectors required for the therapeutic activity of vorinostat. Oncoimmunology (2013) 0.89
HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function. Front Immunol (2016) 0.81
Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment. Gut (2013) 2.28
Influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains. J Bacteriol (2006) 1.76
Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood (2010) 1.76
Diversity of prophages in dominant Staphylococcus aureus clonal lineages. J Bacteriol (2009) 1.61
The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia. Leuk Res (2013) 1.58
Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke (2007) 1.50
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases. Haematologica (2006) 1.47
Heparin-induced thrombocytopenia: further evidence for a unique immune response. Blood (2012) 1.44
egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun (2004) 1.41
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol (2004) 1.39
Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation. Proteomics (2010) 1.27
Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response. Int J Med Microbiol (2009) 1.21
Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens. Nat Commun (2013) 1.15
Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One (2010) 1.10
Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol (2009) 1.09
Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus. J Clin Microbiol (2010) 1.08
Staphylococcal superantigens: do they play a role in sepsis? Arch Immunol Ther Exp (Warsz) (2005) 1.07
Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells. Cancer Lett (2008) 1.02
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice. Oligonucleotides (2006) 0.99
Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells. J Cancer Res Clin Oncol (2007) 0.99
Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Int J Oncol (2006) 0.98
Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics (2011) 0.97
Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients. BMC Cancer (2006) 0.96
Peroxiredoxin III protects pancreatic ß cells from apoptosis. J Endocrinol (2010) 0.95
Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival. Clin Cancer Res (2009) 0.95
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Br J Haematol (2005) 0.93
Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial. Auris Nasus Larynx (2010) 0.93
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging (2010) 0.93
Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro. Mol Cancer Ther (2007) 0.91
Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J Immunol (2008) 0.91
Characterization of a mouse-adapted Staphylococcus aureus strain. PLoS One (2013) 0.91
Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant (2009) 0.90
The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro. Cancer Chemother Pharmacol (2010) 0.89
Sepsis leads to a reduced antigen-specific primary antibody response. Eur J Immunol (2011) 0.89
Foxp3+ regulatory T cells are required for recovery from severe sepsis. PLoS One (2013) 0.88
Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells. Pathol Oncol Res (2007) 0.87
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsis. Crit Care Med (2010) 0.87
Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia. Clin Vaccine Immunol (2011) 0.87
Cytosolic [Ca2+] transients in dictyostelium discoideum depend on the filling state of internal stores and on an active sarco/endoplasmic reticulum calcium ATPase (SERCA) Ca2+ pump. J Biol Chem (2004) 0.86
Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells. Cancer Lett (2006) 0.85
Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells. Eur J Cancer (2011) 0.85
Genomic and proteomic characterization of Staphylococcus aureus mastitis isolates of bovine origin. Proteomics (2011) 0.85
Nuclear factor-kappaB mediates up-regulation of cathepsin B by doxorubicin in tumor cells. Mol Pharmacol (2004) 0.84
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. Invest New Drugs (2005) 0.84
Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. Oncol Rep (2008) 0.84
Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett (2004) 0.83
Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression. Invest New Drugs (2010) 0.83
KRAS-mutated non-small cell lung cancer cells are responsive to either co-treatment with erlotinib or gefitinib and histone deacetylase inhibitors or single treatment with lapatinib. Oncol Rep (2011) 0.83
Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers. PLoS One (2013) 0.82
The alternative sigma factor B modulates virulence gene expression in a murine Staphylococcus aureus infection model but does not influence kidney gene expression pattern of the host. Int J Med Microbiol (2011) 0.82
MALT lymphoma in children: a report from the NHL-BFM Study Group. Pediatr Blood Cancer (2006) 0.81
Impact of the CTLA-4/CD28 axis on the processes of joint inflammation in rheumatoid arthritis. Arthritis Rheum (2013) 0.81
Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous system. J Pediatr Hematol Oncol (2006) 0.81
Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents. Br J Haematol (2012) 0.80
Poor outcome of two children with relapsed state stage IV alveolar rhabdomyosarcoma after allogeneic stem cell transplantation. Pediatr Hematol Oncol (2005) 0.79
Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation. Cancer Biol Ther (2012) 0.78
Histone deacetylase inhibitors, but not vincristine, cooperate with radiotherapy to induce cell death in medulloblastoma. Anticancer Res (2007) 0.78
Establishment of a one-sided ex vivo human placenta perfusion model to assess adhesion and invasion behavior of T cell leukemia cell lines. Leuk Lymphoma (2013) 0.78
Down-regulation of protein kinase Ceta potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells. Mol Cancer Ther (2004) 0.78
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. Br J Haematol (2005) 0.77
CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian children. Trop Med Int Health (2003) 0.77
Differential responsiveness of human hepatoma cells versus normal hepatocytes to TRAIL in combination with either histone deacetylase inhibitors or conventional cytostatics. Cancer Sci (2008) 0.77
Experimental sepsis impairs humoral memory in mice. PLoS One (2013) 0.77
Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. Anticancer Res (2003) 0.77
Substantially reduced calcaneal bone ultrasound parameters in severe untreated asthma. Respiration (2009) 0.76
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. Oncol Rep (2006) 0.76
Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells. Anticancer Drugs (2007) 0.76
Altered immune proteome of Staphylococcus aureus under iron-restricted growth conditions. Proteomics (2014) 0.76
NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation. Blood (2011) 0.76
Serine proteases in histone deacetylase inhibitor-induced apoptosis. Mol Cancer Ther (2010) 0.75
Full activation of CD4+ T cells early during sepsis requires specific antigen. Shock (2015) 0.75
Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation. Int J Oncol (2004) 0.75
The case of a 1-year-old girl with hereditary hyperferritinemia cataract syndrome. Pediatr Hematol Oncol (2009) 0.75
Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients. Mult Scler (2011) 0.75
Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin. J Pediatr Endocrinol Metab (2014) 0.75
Corrigendum: Wall teichoic acids mediate increased virulence in Staphylococcus aureus. Nat Microbiol (2017) 0.75
Busulfan induces activin A expression in vitro and in vivo: a possible link to venous occlusive disease. Clin Pharmacol Ther (2003) 0.75
Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. Pathol Biol (Paris) (2005) 0.75
A pediatric prognostic score for patients undergoing allogeneic hematopoietic stem cell transplantation. Eur J Haematol (2014) 0.75
The guardians at the gate. Trends Immunol (2002) 0.75